Both stocks run through our valuation models. Here is how Evoq Remedies (EVOQ) and McKesson (MCK) compare, as of Aug 25, 2026.
As of Aug 25, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Evoq Remedies trades at ₹1.76 versus a fair value of ₹1.23 (-30%), while McKesson trades at $874 versus $819 (-6%).
Evoq Remedies
EVOQ.BSE · INR · Health Care
-30%
upside to fair value
overvalued
Price₹1.76
Fair Value₹1.23
Quality46/100
McKesson
MCK · USD · Health Care
-6%
upside to fair value
fairly valued
Price$874
Fair Value$819
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Evoq RemediesMcKesson
Valuation
—P/E (TTM)21.0×
—P/S (TTM)0.23×
—EV/EBITDA13.9×
—PEG1.57×
—Dividend yield0.4%
—Dividend per share$3.17
Profitability
-1%Net margin1%
-175%Operating margin2%
-1%Return on equity—
-0%Return on assets5%
Growth
-99%Revenue growth (YoY)6%
7.7%Avg. growth/yr (3Y)13.4%
20.5%Avg. growth/yr (5Y)11.1%
Balance & size
$0MMarket cap$94B
mixedGrowth qualityhealthy
McKesson leads: 1 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Evoq Remediesof which business quality 46 · market factors 5McKessonof which business quality 65 · market factors 63
ProfitabilityMargins and returns on capital today
14
49
Quality GrowthAre margins and returns improving?
86
65
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
43
76
Low VolatilityCalm price path (market factor)
15
83
MomentumPrice trend over the last 3–12 months (market factor)
0
51
52W MomentumDistance to the 52-week high (market factor)
2
63
Net IssuanceBuybacks instead of dilution
40
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Evoq Remedies
Asset-Based₹11.92
0 of 1 models see the stock below the current price.
McKesson
DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708
13 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Evoq Remedies
Bear ₹0.81Fair Value ₹1.23Bull ₹1.53
₹1.76 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$874 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Evoq Remedies · Health Care
Quality score46 · below median
Fair value upside-30% · above median
McKesson · Health Care
Quality score67 · Top 25%
Fair value upside-6% · above median
Bottom line
As of Aug 25, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Evoq Remedies trades at ₹1.76 versus a fair value of ₹1.23 (-30%), while McKesson trades at $874 versus $819 (-6%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.
